Elon Musk's Ketamine Use Excluded from OpenAI Trial

Elon Musk's use of the drug ketamine will not be considered in the upcoming jury trial involving OpenAI and its CEO, Sam Altman. Bloomberg posted on X, the trial centers on allegations that OpenAI defrauded Musk by moving away from its nonprofit origins. The decision to exclude details about Musk's ketamine use was made to keep the focus on the core issues of the case. The trial will proceed with attention on the claims of fraud and the operational changes at OpenAI.